| References: | (1) Page, M. I. Enzyme Inhibition. In Comprehensive Medicinal
Chemistry; Sammes, P. G., Ed.; Pergamon Oxford, 1990; Vol. 2,
pp 61-87.
(2) (a) Wharton, C. W. The Serine Proteinases. In Comprehensive
Biological Catalysis; Sinnott, M., Ed; Academic Press: London,
1997; Vol. 1, Chapter 11, pp 345-379. (b) Underwood, D. J.;
Green, B. G.; Chabin, R.; Mills, S.; Doherty, J. B.; Finke, P. E.;
MacCoss, M.; Shah, S. K.; Burgey, C. S.; Dickinson, T. A.; Griffin,
P. R.; Lee, T. E.; Swiderek, K. M.; Covey, T.; Westler, W. M.;
Knight, W. B. Mechanism of inhibition of human leukocyte
elastase by beta lactams. 2. Stability, reactivation kinetics, and
products of â lactam derived E-I complexes. Biochemistry 1995,
34, 14344-14355. (c) Katzenellenbogen, J. A.; Rai, R.; Dai, W.
Enol-lactone derivatives as inhibitors of human neutrophil
elastase and trypsin like proteases. Bioorg. Med. Chem. Lett. 2,
1992, 11, 1399-1404. (d) Knight, W. B.; Maycock, A. L.; Green,
B. G.; Ashe, B. M.; Gale, P.; Weston, H.; Finke, P. E.; Hagmann,
W. K.; Shah, S. K.; Doherty, J. B. Mechanism of inhibition of
human leukocyte elastase by two cephalosporin derivatives.
Biochemistry 1992, 31, 4980-4986. (e) Kam, C.-M.; Fujikawa,
K.; Powers, J. C. Mechanism-based isocoumarin inhibitors for
trypsin and blood coagulation serine proteases: new anticoagulants.
Biochemistry 1988, 27, 2547-2557. (f) Navia, M. A.;
Springer, J. P.; Lin, T. Y.; Williams, H. R.; Firestone, R. A.;
Pisano, J. M.; Doherty, J. B.; Finke, P. E.; Hoogsteen, K.
Crystallographic study of a beta-lactam inhibitor complex with
elastase at 1.84 Å resolution. Nature 1982, 327, 79-82. (g) Copp,
L. J.; Krantz, A.; Spencer, R. W. Kinetics and mechanism of
human leukocyte elastase inactivation by ynenol lactones.
Biochemistry 1987, 26, 169-178. (h) Gelb, M. H.; Abeles, R. H.
Substituted isatoic anhydrides: selective inactivators of trypsin
like serine proteases. J. Med. Chem. 1986, 29, 585-589. (i) Gelb,
M. H.; Abeles, R. H. Mechanism of inactivation of chymotrypsin
by 3-benzyl-6-chloro-2-pyrone. Biochemistry 1984, 23, 6569-
6604.
(3) Slater, M. J.; Laws, A. P.; Page, M. I. The relative catalytic
efficiency of beta lactamase catalysed acyl and phosphyl transfer.
Bioorg. Chem. 2001, 29, 77-95.
(4) Beardsell, M.; Hinchliffe, P. S.; Wood, J. M.; Wilmouth, R. C.;
Schofield, C. J.; Page, M. I. Beta-sultamssa novel class of serine
protease inhibitors. Chem. Commun. 2001, 497-498.
(5) Page, M. I. Enzyme Catalysis. In Comprehensive Medicinal
Chemistry; Sammes, P.,G., Ed.; Pergamon: Oxford, 1990; Vol.
2, pp 45-60.
(6) (a) Laws, A. P.; Page, M. I. The effect of the carboxyl group on
the chemical and beta-lactamase reactivity of beta-lactam
antibiotics. J. Chem. Soc., Perkin Trans. 2 1989, 1577-1581.
(b) Laws, A. P.; Layland, N. J.; Proctor, D. G.; Page, M. I. The
roles of the carboxy group in beta-lactam antibiotics and lysine-
234 in beta-lactamase I. J. Chem. Soc., Perkin Trans 2 1993,
17-21.
(7) Metz, W. A.; Peet, N. P. Elastase inhibitors. Prog. Inflammation
Res. 1999, 9, 853-868.
(8) (a) Bode, W.; Wei, A. Z.; Huber, R.; Meyer, E.; Travis, J.;
Neuman, S. X-Ray crystal structure of the complex of human
leukocyte elastase (PMN elastase) and the third domain of the
turkey ovomucoid inhibitor. EMBO J. 1986, 5, 2453-2458. (b)
Navia, M. A.; McKeever, B. M.; Springer, J. P.; Lin, T. Y.;
Williams, H. R.; Fluder, E. M.; Dorn, C. P.; Hoogsteen, K.
Structure of human neutrophil elastase in complex with a
peptide chloromethyl ketone inhibitor at 1.84 Å resolution. Proc.
Natl. Acad. Sci. U.S.A. 1989, 86, 7-11.
(9) Bode, W.; Meyer, E., Jr.; Powers, J. C. Human and porcine
pancreatic elastase. X-ray crystal structures, mechanism, substrate
specificity, and mechanism-based inhibitors. Biochemistry
1989, 28, 1951-1962.
(10) (a) Takahashi, L. H.; Radhakrishan, R.; Rosenfeld, R. E., Jr.;
Meyer, E. F., Jr.; Trainer, D. A. Crystal structure of the covalent
complex formed by a peptidyl R, R-difluoro-â-keto amide with
porcine pancreatic elastase at 1.78 Å resolution. J. Am. Chem.
Soc. 1989, 111, 3368-3374. (b) Renaud, A.; Lestienne, P.;
Hughes, D. L.; Bieth, J. G.; Dimicoli, J.-L. Mapping the S¢
Subsites of porcine pancreatic and human leukocyte elastases.
J. Biol. Chem. 1983, 258, 8312-8316.
(11) (a) Edwards, P. D.; Meyer, E. F., Jr.; Vijayalakshmi, J.; Tuthill,
P. A.; Andisk, D. A.; Gomes, B.; Strimpler, A. Design, synthesis
and kinetic evaluation of a unique class of elastase inhibitors.
The peptidyl alpha ketobenzoxazoles and the X-ray crystal
structure of the covalent complex between porcine pancreatic
elastase and Ac-Ala-Pro-Val-2-benzoxazole. J. Am. Chem. Soc.
1992, 114, 1854-1863. (b) Costanzo, M. J.; Maryanoff, B. E.;
Hecker, L. R.; Schott, M. R.; Yabut, S. C.; Zhang, H.-C.; Andrade-
Gordon, P.; Kauffman, J. A.; Lewis, J. M.; Krishnan, R.;
Tulinsky, A. Potent thrombin inhibitors that probe the S1¢
subsite: tripeptide transition state analogues based on a heterocycle
activated carbonyl group. J. Med. Chem. 1996, 39,
3039-3043. (c) Bernstein, P. R.; Gomes, B. C.; Kosmider, B. J.;
Vacek, E. P.; Williams, J. C. Nonpeptidic inhibitors of human
leukocyte elastase. 6. Design of a potent intratracheally active,
pyridone based trifluoromethyl ketone. J. Med. Chem. 1995, 38,
212-215. (d) Edwards, P. D.; Andisik, D. W.; Strimpler, A. M.;Gomes, B.; Tuthill, P. A. Nonpeptidic inhibitors of human
neutrophil elastase. 7. Design synthesis and in vitro activity of
pyridopyrimidine trifluoromethyl ketones. J. Med. Chem. 1996,
39, 1112-1124. (e) Angelastro, M. R.; Bey, P.; Burhart, J. P.;
Chen, T.-M.; Cregge, R. J.; Durham, S. L.; Farr, R. A.; Gallion,
S. L.; Hare, C. M.; Hoffmann, R. V.; Huber, E. W.; Janusz, M.
L.; Kim, H.-O.; Koehl, J. R.; Marquart, A. L.; Mehdi, S.; Metz,
W. A.; Peet, N. P.; Schreuder, H. A.; Sunder, S.; Tardif, C.
Inhibition of human neutrophil elastase. 4. Design, synthesis,
X-ray crystallographic analysis, and structure-activitiy relationships
for a series of nonpeptidic, orally active pentafluoroethyl
ketones. J. Med. Chem. 1998, 41, 2461-2480.
(12) (a) Macdonald, S. J. F.; Belton, D. B.; Buckley, D. M.; Spooner,
J. E.; Anson, M. S.; Harrison, L. A.; Mills, K.; Upton, R. J.; Dowle,
M. D.; Smith, R. A.; Molloy, C.; Risley, C. Syntheses of trans-
5-oxohexahydropyrrolo[3,2-b]pyrroles and trans-5-oxohexahydrofuro[
3,2-b]pyrroles (pyrrolidine trans-lactams and translactones):
new pharmacophores for elastase inhibition J. Med.
Chem. 1998, 41, 3919-3922. (b) Macdonald, S. J. F.; Dowle, M.
D.; Harrison, L. A.; Spooner, J. E.; Shah, P.; Johnson, M. R.;
Inglis, G. G. A.; Clarke, G. D. E.; Belton, D. J.; Smith, R. A.;
Molloy, C. R.; Dixon, M.; Murkitt, G.; Godward, R. E.; Skarzynski,
T.; Singh, O. M. P.; Kumar, K. A.; Hodgson, S. T.; McDonald,
E.; Hardy, G. W.; Finch, H.; Fleetwood, G.; Humphreys, D. C.
Intracellular inhibition of human neutrophil elastase by orally
active pyrrolidine-trans-lactams Bioorg. Med. Chem. Lett. 2001,
11, 243-246. (c) Macdonald, S. J. F.; Dowle, M. D.; Harrison, L.
A.; Shah, P.; Johnson, M. R.; Inglis, G. G. A.; Clarke, G. D. E.;
Smith, R. A.; Humphreys, D.; Molloy, C. R.; Amour, A.; Dixon,
M.; Murkitt, G.; Godward, R. E.; Padfield, T.; Skarzynski, T.;
Singh, O. M. P.; Kumar, K. A.; Fleetwood, G.; Hodgson, S. T.;
Hardy, G. W.; Finch, H. The discovery of a potent, intracellular,
orally bioavailable, long duration inhibitor of human neutrophil
elastase-GW311616A a development candidate. Bioorg. Med.
Chem. Lett. 2001, 11, 895-898.
(13) (a) Page, M. I. Structure-activity relationships: chemical. In
The Chemistry of â-Lactam Antibiotics; Page, M. I., Ed.; Blackie:
Glasgow, 1992; Chapter 2, pp 79-100. (b) Page, M. I. The
mechanisms of reactions of beta-lactam antibiotics. Adv. Phys.
Org. Chem. 1987, 23, 165-270. (c) Page, M. I. The mechanisms
of reactions of â-lactam anytibiotics. Acc. Chem. Res. 1984, 17,
144-151.
(14) Allinger, N. L.; Tribble, M. T.; Miller, M. A.; Westz, D. H.
Conformational analysis. LXIX. An improved force field for the
calculation of the structures and energies of hydrocarbons. J.
Am. Chem. Soc. 1971, 93, 1637-1648.
(15) King, J. F.; Rathore, R.; Lam, J. Y. L.; Gao, L. E. R.; Klassen,
D. F. pH optimization of nucleophilic reactions in water. J. Am.
Chem. Soc. 1992, 114, 3028-3033.
(16) (a) Groutas, W. C.; Houser-Archield, N.; Chong, L. S.; Venkateraman,
R.; Epp, J. B.; Huang, H.; McClenahan, J. J. Efficient
inhibition of human leukocyte elastase and cathepsin G by
saccharin derivatives. J. Med. Chem. 1993, 36, 3178-3184. (b)
Hlasta, D. J.; Bell, M. R.; Boaz, N. W.; Court, J. J.; Desai, R. C.;
Franke, C. A.; Mura, A. J.; Subramanyam, D.; Dunlap, R. P. A
Benzisothiazolone class of potent selective mechanism based
inhibitors of human leukocyte elastase. Bioorg. Med. Chem Lett.
1994, 4, 1801-1804.
(17) (a) Wood, J. M.; Page, M. I. The mechanisms of sulfonyl transfer
in strained cyclic sulfonamides. Trends Heterocycl. Chem., in
press. (b) Terrier, F.; Kizilian, E.; Gaumont, R.; Faucher, N.;
Wakselman, C. R-Sulfonyl carbanions. combined kinetic, thermodynamic,
and NMR approaches for the study of the ionization
of benzyltriflones in Me2SO and H2O-MeSO2 mixtures. J. Am.
Chem. Soc. 1998, 120, 9496-9503.
(18) Hinchliffe, P. S.; Wood, J. M.; Davis, A.M.; Austin, R. P.; Beckett,
R. P.; Page, M. I. Unusual steric effects in sulfonyl transfer
reactions. J. Chem. Soc., Perkin Trans. 2 2001, 1503-1505.
(19) Huisgen, R.; Ott, H, Die konfiguration der carbonestergruppe
und die sondereigenschaften der lactone (the configuration of
the ester group and the special properties of lactones). Tetrahedron
1959, 6, 253-261. Blackburn, G. M.; Dodds, H. L. H.
Strain effects in acyl transfer reactions. Part 3. Hydroxide and
buffer catalysed hydrolysis of small and medium ring lactones.
J. Chem. Soc., Perkin Trans. 2 1974, 377-382.
(20) Macchia, B.; Gentili, D.; Macchia, M.; Mamone, F.; Martinelli,
A.; Orlandini, E.; Rossello, A.; Cercignani, G.; Perotti, R.;
Allegretti, M.; Asti, C.; Caselli, G. Synthesis, inhibitory activity
towards human leukocyte elastase and molecular modelling
studies of 1-carbomyl-4-methyleneaminoxyazetadinones. Eur. J.
Med. Chem. 2000, 35, 53-67.
(21) (a) Smith, G. B.; Schoenewaldt, E. F. Stability of N-formidoylthienamycin
in aqueous solution. J. Pharm. Sci. 1981, 70, 272-
276. (b) Proctor, P.; Gensmantel, N. P.; Page, M. I. The Chemical
Reactivity of Penicillins and Other â-Lactam Antibiotics. J.
Chem. Soc. Perkin Trans. 2 1982, 1135-1192. (c) Proctor, P.;
Page, M. I. The Mechanism of â-Lactam Ring Opening in
Cephalosporins. J. Am. Chem. Soc. 1984, 106, 3820-3825. (d)
Fersht, A. R.; Kirby, A. J. The hydrolysis of aspirin. J. Am. Chem.
Soc. 1967, 89, 4857-4863 (e) Haginaka, J.; Nakagawa, T.; Uno,
T. Stability of clavulanic acid in aqueous solutions. Chem.
Pharm. Bull. 1981, 29, 3334-3341. |
|---|
Tools
Tools